Trials / Completed
CompletedNCT03366207
Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
Clinical and Microbiologic Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection in Adult Women.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Iterum Therapeutics, International Limited · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, Phase 4, open label, multi-center study of the clinical and microbiologic efficacy of ciprofloxacin for the treatment of uncomplicated urinary tract infections in adult women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ciprofloxacin | Ciprofloxacin 250 mg PO twice daily (BID) x 3 days for women with uUTI. |
Timeline
- Start date
- 2017-12-15
- Primary completion
- 2018-07-31
- Completion
- 2018-10-26
- First posted
- 2017-12-08
- Last updated
- 2019-09-06
- Results posted
- 2019-08-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03366207. Inclusion in this directory is not an endorsement.